Poniard Pharmaceuticals Garners $6,300,000 New Funding Round

  • Feed Type
  • Date
    3/16/2010
  • Company Name
    Poniard Pharmaceuticals
  • Mailing Address
    7000 Shoreline Court South San Francisco, CA 94080
  • Company Description
    Poniard Pharmaceuticals, Inc. (NASDAQ: PARD) is a biopharmaceutical company focused on the development and commercialization of innovative oncology products to impact the lives of people with cancer.
  • Website
    http://investor.poniard.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $6,300,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    The firm said the funding will go to fund continued development of its treatments for small cell lung cancer.
  • M&A Terms
  • Venture Investor
    Undisclosed

Trending on Xconomy